Healthcare Management News - Merrill Lynch Cuts Boston Scientific To Neutral From Buy

NEW YORK -(Dow Jones)- Merrill Lynch cut its rating on Boston Scientific Corp. ( BSX) to neutral from buy, citing estimates that the medical products company's share of the U.S.

http://c.moreover.com/click/here.pl?r397575309